Dr Nadine Hillock
School of Public Health
College of Health
Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.
Dr Nadine Hillock is a public health researcher and pharmacist with expertise in antimicrobial stewardship and resistance, health policy and economics and project management. She has a Bachelor of Pharmacy and Postgraduate Diploma in Clinical Pharmacy from the University of Otago (NZ), a Masters in Public Health from the University of Sydney and a PhD from the University of Adelaide. Her PhD thesis was titled Investigating an alternative regulatory and reimbursement framework for antimicrobials in Australia. Her current research interests include pharmacoepidemiology, antimicrobial surveillance methodology, antimicrobial stewardship and health economics. Dr Hillock has over 25 years experience in healthcare across a variety of sectors including hospital, community, industry and government. She managed the National Antimicrobial Utilisation Surveillance Program, a key component of the One Health surveillance network for antimicrobial use and resistance in Australia (AURA).She has been a member of a number of national and state committees, including: - Australian Antimicrobial Stewardship Advisory Committee - South Australian expert Advisory Group on Antimicrobial Resistance (SAAGAR) - South Australian Medicines Evaluation Panel (SAMEP) - South Australian Antimicrobial Resistance Action Plan Steering Committee (SAAMRAP) - Australian Antimicrobial Stewardship Jurisdictional NetworkDr Hillock is a regular peer reviewer for the Australian Health Review, PharmacoEconomics and JAC-Antimicrobial Resistance journals, as well as a number of other peer-reviewed journals and conferences. As a consultant, she has provided expert advice to reviews commissioned by the Australian Government Department of Health and Aged Care.
Dr Hillock's current research interests include antimicrobial surveillance methodology, antimicrobial stewardship, pharmacoepidemiology and public health.
| Date | Position | Institution name |
|---|---|---|
| 2023 - 2025 | Affiliate Senior Lecturer | University of Adelaide |
| 2019 - ongoing | Senior Pharmacist | Program Manager, National Antimicrobial Utilisation Surveillance Program (NAUSP) | SA Health |
| 2016 - 2019 | Public Health Pharmacist | SA Health |
| 2016 - 2016 | Clinical Pharmacist / Practice Support | Drug & Therapeutics Information Service (DATIS), SA Health |
| 2015 - 2015 | Tutor | Public Health, University of Adelaide, Adelaide |
| 2010 - 2016 | Senior Pharmacist | South Australian Medicines Evaluation Panel, SA Health |
| 2009 - 2010 | Project Pharmacist | National Antimicrobial Utilisation Serveillance Programs (NAUSP) |
| 2007 - 2009 | Production Pharmacist | Flinders Medical Centre, SA Health |
| 2005 - 2016 | Radiopharmacist | Lantheus Medical Imaging (formally Bristol-Myers Squibb Medical Imaging) |
| 1998 - 2004 | Community Pharmacist / Dispensary Manager | Christchurch, NZ |
| 1997 - 1997 | Aseptic services / Oncology pharmacist | Hawkes Bay District Health Board, NZ |
| 1996 - 1997 | Locum hospital pharmacist | Australia & UK |
| 1994 - 1996 | Clinical Pharmacist | St George Hospital, Sydney |
| 1993 - 1994 | Intern Pharmacist | Tairawhiti District Health Board, NZ |
| Date | Type | Title | Institution Name | Country | Amount |
|---|---|---|---|---|---|
| 2019 | Award | Neville Derrington Hicks PhD Scholarship in Public Health Policy | University of Adelaide | Australia | - |
| 2017 | Scholarship | Divisional Scholarship, Faculty of Health Sciences | University of Adelaide | - | - |
| 2014 | Award | SA Health Award - Excellence in non-clinical services (SAMEP) | SA Health | - | - |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2017 - 2022 | University of Adelaide, Adelaide | Australia | Doctor of Philosophy |
| 2010 - 2013 | University of Sydney, Sydney | Australia | Master of Public Health |
| 1997 - 2000 | University of Otago, Dunedin | New Zealand | Post-graduate diploma in Clinical Pharmacy |
| 1988 - 1992 | University of Otago, Dunedin | New Zealand | Bachelor of Pharmacy |
| Date | Title | Institution | Country |
|---|---|---|---|
| 2023 - 2023 | Applied Learning Health Systems | University of Melbourne | Australia |
| 2021 - 2021 | Leading Clinicians Program | SA Health | Australia |
| Health Technology Assessment | University of Adelaide | Australia | |
| Financial Planning | Massey University, Palmerston North | New Zealand | |
| Radiation safety & radiopharmaceutical manufacturing | BMS Medical Imaging | Australia |
| Date | Title | Institution name | Country |
|---|---|---|---|
| — | Registered Pharmacist | Australian Health Practitioner Regulation Agency (AHPRA) | - |
| Year | Citation |
|---|---|
| 2025 | Hillock, N. T., Cheng, A., & Bowskill, A. (2025). Do policies that allow access to unregistered antimicrobials address the unmet need? Australia as a case study of a high-income country with universal healthcare. Jac Antimicrobial Resistance, 7(1), 9 pages. |
| 2025 | Hillock, N., Raby, E., & Rawlins, M. (2025). Off-label use of intravenous rifampicin during surgery: analysis of Australian surveillance data and retrospective audit at a tertiary hospital. Antimicrobial Stewardship & Healthcare Epidemiology, 5(1), e100-1-e100-7. |
| 2024 | Maher, D., Sluggett, J. K., Soriano, J., Hull, D. -A., & Hillock, N. T. (2024). Surveillance of Antimicrobial Use in Long-Term Care Facilities: An Antimicrobial Mapping Survey. Journal of the American Medical Directors Association (JAMDA): long-term care: management, applied research and clinical issues, 25(9), 105144-1-105144-7. WoS1 Europe PMC2 |
| 2024 | Dalwai, A., & Hillock, N. (2024). Antimicrobial surveillance in South Australian prisons: a pilot study. Australian Health Review, 48(5), 539-545. Scopus1 WoS1 |
| 2023 | Teoh, A. P. K., & Hillock, N. (2023). Antimicrobial-impregnated bone cement use in Australian hospitals: scoping pharmacist awareness and involvement in management. Journal of Pharmacy Practice and Research, 53(2), 73-78. |
| 2023 | Hillock, N. T., Campbell, D. G., Nelson, R., Teoh, A., Tan, J., & Smitham, P. (2023). Antimicrobial-loaded bone cement use is highly variable in joint replacement surgery: a survey of Australian arthroplasty surgeons. ANZ Journal of Surgery, 93(6), 1467-1470. Scopus1 WoS1 Europe PMC1 |
| 2023 | Lai, T., Thiele, H., Rogers, B. A., Hillock, N., Adhikari, S., McNamara, A., & Rawlins, M. (2023). Exploring the advancements of Australian OPAT. Therapeutic Advances in Infectious Disease, 10, 12 pages. Scopus8 WoS8 Europe PMC4 |
| 2022 | Connor, E., Rasiah, K., & Hillock, N. (2022). Utilisation of antimicrobials used to treat bacterial pneumonia in principal referral hospitals during the COVID-19 pandemic, Australia, 2020. Communicable Diseases Intelligence 2018, 46, 14 pages. WoS2 |
| 2022 | Hillock, N. T., Merlin, T. L., Turnidge, J., & Karnon, J. (2022). Modelling the Future Clinical and Economic Burden of Antimicrobial Resistance: The Feasibility and Value of Models to Inform Policy. Applied Health Economics and Health Policy, 20(4), 479-486. Scopus25 WoS19 Europe PMC15 |
| 2022 | Macauley, G., Penny, M., McNeil, V., Gustafsson, T., & Hillock, N. (2022). Impact of expired stock on antimicrobial surveillance in rural hospitals: implications and challenges for stewardship. Journal of Pharmacy Practice and Research, 52(5), 371-377. |
| 2021 | Hillock, N. T., Merlin, T. L., Karnon, J., Turnidge, J., & Eliott, J. (2021). Value assessment of antimicrobials and the implications for development, access, and funding of effective treatments: Australian stakeholder perspective.. International journal of technology assessment in health care, 37(1), 1-7. Scopus2 WoS2 Europe PMC2 |
| 2021 | Hillock, N. T., Connor, E., Wilson, C., & Kennedy, B. (2021). Comparative analysis of Australian hospital antimicrobial utilization, using the WHO AWaRe classification system and the adapted Australian Priority Antimicrobial List (PAL). Jac Antimicrobial Resistance, 3(1), 5 pages. Scopus4 WoS7 Europe PMC4 |
| 2021 | Lambert, R., Burgess, N., Hillock, N., Gailer, J., Hissaria, P., Merlin, T., . . . Hill, C. (2021). South Australian Medicines Evaluation Panel in review: providing evidence-based guidance on the use of high-cost medicines in the South Australian public health system. Australian Health Review, 45(2), 207-213. |
| 2020 | Hillock, N. T., Karnon, J., Turnidge, J., & Merlin, T. L. (2020). Estimating the utilisation of unregistered antimicrobials in Australia. Infection, Disease and Health, 25(2), 82-91. |
| 2020 | Hillock, N. T., Merlin, T., Karnon, J., Turnidge, J., & Eliott, J. (2020). Feasibility of de-linking reimbursement of antimicrobials from sales: the Australian perspective as a qualitative case study. Journal of Antimicrobial Chemotherapy - Antimicrobial Resistance, 2(2), 1-7. Scopus3 WoS2 Europe PMC1 |
| 2019 | Hillock, N. T., Paradiso, L., Turnidge, J., Karnon, J., & Merlin, T. (2019). Clinical indications treated with unregistered antimicrobials: The regulatory challenges of antimicrobial resistance and access to effective treatment for patients. Australian Health Review, 44(2), 263-269. Scopus2 WoS2 Europe PMC1 |
| 2019 | Hillock, N., Hillock, R., & Warner, M. (2019). Antibacterial envelope to prevent cardiac implantable device infection. New England Journal of Medicine, 381(18), 1782. Scopus3 WoS3 Europe PMC4 |
| 2018 | Hillock, N. (2018). Is obesity fake news?. Pharmacy Growth, Research, Innovation and Training, 2(4). |
| 2017 | Hillock, N. T., Heard, S., Kichenadasse, G., Hill, C. L., & Andrews, J. (2017). Infliximab for ipilimumab-induced colitis: A series of 13 patients. Asia-Pacific Journal of Clinical Oncology, 13(5), e284-e290. Scopus38 WoS32 Europe PMC24 |
| 2016 | Hillock, N. (2016). The challenge of costly drugs. Australian Prescriber, 39(5), 149. |
| Year | Citation |
|---|---|
| 2022 | Connor, E., & Hillock, N. (2022). 57: NAUSP METHODOLOGY UPDATES AND APPLICATION OF THE PRIORITY ANTIBACTERIAL LIST IN AUSTRALIAN ACUTE-CARE HOSPITALS, 2019–21. In Journal of Global Antimicrobial Resistance Vol. 31 (pp. S33-S34). Elsevier BV. DOI |
| Year | Citation |
|---|---|
| 2025 | Hillock, N., Raby, E., & Rawlins, M. (2025). Undocumented rifampicin use during surgery: Opportunities for antimicrobial stewardship. Poster session presented at the meeting of Antimicrobials 2025. Melbourne. |
| 2025 | Hillock, N. (2025). Undocumented rifampicin use during surgery: Opportunities for antimicrobial stewardship. Poster session presented at the meeting of Antimicrobials 2025. Melbourne. |
| 2024 | Hillock, N., Maher, D., Dalwai, A., & Connor, E. (2024). Trends in systemic antifungal usage rates in Australian hospitals: 2018-2022 (poster). Poster session presented at the meeting of Antimicrobials 2024: 23rd Annual Scientific Meeting. Sydney. |
| 2024 | Maher, D., Sluggett, J., Soriano, J., Hull, D. -A., & Hillock, N. (2024). Surveillance of antimicrobial use in residential aged care: An Australian antimicrobial mapping survey. Poster session presented at the meeting of Antimicrobials 2024: 23rd Annual Scientific Meeting. |
| 2024 | Hillock, N. (2024). NAUSP: Data update and future opportunities (oral). Poster session presented at the meeting of Antimicrobials 2024: 23rd Annual Scientific Meeting. |
| 2023 | Hillock, N., Connor, E., & Dalwai, A. (2023). Antifungal usage rates in Australian hospitals. Poster session presented at the meeting of Antimicrobials 2023: 22nd Annual Scientific Meeting. Brisbane. |
| 2023 | Hillock, N. (2023). Antimicrobial-loaded bone cement in prosthetic joint surgery: Current practice and opportunities for antimicrobial stewardship (oral presentation). Poster session presented at the meeting of Antimicrobials 2023: 22nd Annual Scientific Meeting. Brisbane. |
| 2021 | Hillock, N., Connor, E., & McNeil, V. (2021). Hospital antibiotic use during the first COVID-19 wave in Australia (online oral presentation). Poster session presented at the meeting of ASA online. |
| 2020 | Wilson, C., Connor, E., & Hillock, N. (2020). Increasing antifungal use in Australian hospitals (poster presentation). Poster session presented at the meeting of National Centre for Antimicrobial Stewardship Antimicrobial Awareness Week Online. |
| 2020 | Wilson, C., Connor, E., & Hillock, N. (2020). Increasing antifungal use in Australian hospitals (poster presentation). Poster session presented at the meeting of National Centre for Antimicrobial Stewardship Antimicrobial Awareness Week Online. |
| 2019 | McNeil, V., Hillock, N., & Warner, M. (2019). The South Australian Expert Advisory Group on Antimicrobial Resistance: 10 years progress and challenges. Poster session presented at the meeting of Australian Society for Antimicrobials 2019. Sydney. |
| 2019 | Hillock, N. T., Turnidge, J., Karnon, J., & Merlin, T. (2019). Policy incentives for a sustainable antibiotic market: the perspective of Australian stakeholders - a qualitative study (poster presentation). Poster session presented at the meeting of Australian Society for Antimicrobials 2019. |
| 2019 | Hillock, N. T., Paradiso, L., Turnidge, J., Karnon, J., & Merlin, T. (2019). Special Access Scheme Category C and antimicrobial drugs - a policy solution or a temporary fix? (poster presentation). Poster session presented at the meeting of Australian Society for Antimicrobials 2019. |
| 2018 | Hillock, N. T. (2018). Antimicrobial drugs and the Special Access Scheme: an anomaly or a marker of a system in crisis (Oral presentation). Poster session presented at the meeting of National Medicines Symposium. Canberra. |
| 2017 | Hillock, N. T., Turnidge, J., Karnon, J., & Merlin, T. (2017). Investigating the utilisation of unregistered antimicrobial drugs in Australia. Poster session presented at the meeting of Florey Postgraduate Research Conference. Adelaide. |
| 2016 | Hillock, N. T. (2016). Nuclear medicine and the clinical pharmacist: a pathway to incorporating radiopharmaceuticals in the medication management process. Poster session presented at the meeting of National Medicines Symposium. Canberra. |
| 2016 | Hillock, N. T. (2016). Starting from scratch: The South Australian Medicines Evaluation Panel (oral presentation). Poster session presented at the meeting of Canadian Agency for Drugs and Technologies in Health (CADTH) Symposium. Ottawa. |
| 2015 | Hillock, N. T., Selva-Nayagam, S., Hill, C., & Gailer, J. (2015). How systematic review methodology can mislead: Adalimumab versus infliximab for the treatment of Hidradenitis suppurativa (poster presentation). Poster session presented at the meeting of Medicines Management (SHPA) Conference. Melbourne. |
| 2014 | Hillock, N. T., Gailer, J., Rolan, P., & Hill, C. (2014). South Australian Medicines Evaluation Panel: Evolution from inception to now (poster presentation). Poster session presented at the meeting of National Medicines Symposium. Brisbane. |
| 2014 | Gailer, J., Hillock, N. T., Hill, C., & Louise, J. (2014). How to count the eggs? An ethical dilemma (poster presentation). Poster session presented at the meeting of National Medicines Symposium. Brisbane. |
| 2014 | Louise, J., Della Flora, E., & Hillock, N. (2014). Patient self-funding of high cost medications - what are the ethical issues? (oral presentation). Poster session presented at the meeting of National Medicines Symposium. Brisbane. |
| 2013 | Hillock, N. T., Ward, M., Rolan, P., & Hill, C. (2013). A statewide evaluation process for high cost medicines: The challenges of a poor evidence base (poster presentation). Poster session presented at the meeting of Medicines Management (SHPA) Conference. Cairns. |
| 2013 | Hillock, N. T., Ward, M., Rolan, P., & Hill, C. (2013). Defibrotide for treatment or prophylaxis of veno-occlusive disease: What is the evidence? (Poster presentation). Poster session presented at the meeting of Medicines Management (SHPA) Conference. Cairns. |
| Year | Citation |
|---|---|
| 2016 | Hillock, N. T. (2016). Total knee arthroplasty: Continuous passive motion (Evidence summary). Joanna Briggs Institute EBP Database. |
| 2016 | Hillock, N. T. (2016). Post-stroke fatigue: Assessment (Scales) (Evidence Summary). Joanna Briggs Institute EBP Database. |
| 2016 | Hillock, N. T. (2016). Autism Spectrum Disorders: Omega-3 Fatty Acids (Evidence summary). Joanna Briggs Institute EBP Database. |
| 2016 | Hillock, N. T. (2016). Autism Spectrum Disorders: Gluten-Free Casein-Free Diet (Evidence summary). Joanna Briggs Institute EBP Database. |
| 2016 | Hillock, N. T. (2016). Psoriasis: Topical treatments for Chronic Plaque Psoriasis (Evidence summary). Joanna Briggs Institute EBP Database. |
| 2016 | Hillock, N. T. (2016). Cerebral palsy: Speech and Language Therapy for Communication (Children) (Evidence summary). Joanna Briggs Institute EBP Database. |
| 2016 | Hillock, N. T. (2016). Post-stroke fatigue: Management (Evidence summary). Joanna Briggs Institute EBP Database. |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2024 | Co-Supervisor | Development of antimicrobial stewardship programs to limit inappropriate antimicrobial prescriptions for presumed UTIs in residential aged care facilities. | Master of Philosophy (Public Health) | Master | Full Time | Miss Maria Lin |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2022 - ongoing | Member | SA Antimicrobial Resistance Action Plan Steering Committee | SA Health | Australia |
| 2019 - ongoing | Member | AMS Advisory Committee | ACSQHC | Australia |
| 2019 - ongoing | Member | Inter-jurisdictional Antimicrobial Stewardship committee | National Centre for AMS | Australia |
| 2019 - ongoing | Member | Australian Walking and Cycling Conference Organising Committee | Australian Walking and Cycling Conference | Australia |
| 2017 - ongoing | Member | South Australian expert Advisory Group on Antimicrobial Resistance (SAAGAR) | SA Health | Australia |
| 2015 - 2017 | Member | Australian Rheumatology Association - Therapeutics Subcommittee | - | Australia |
| 2010 - 2016 | Co-Founder | South Australian Medicines Evaluation Panel | SA Health | Australia |
| Date | Role | Membership | Country |
|---|---|---|---|
| 2017 - ongoing | - | Australian Society for Infectious Diseases (ASID) | - |
| 2017 - ongoing | - | Australian Society of Antimicrobials | - |
| 2016 - 2016 | Member | Health Technology Assessment International (HTAi) | - |
| 2014 - ongoing | - | Public Health Association of Australia | - |
| 2013 - ongoing | - | International Society for Pharmacoeconomics and Outcomes Research (ISPOR) | - |
| 2008 - ongoing | - | Society of Hospital Pharmacists of Australia | - |
| Date | Title | Type | Institution | Country |
|---|---|---|---|---|
| 2019 - ongoing | Peer reviewer, Am J Inf Cont | Peer Review | American Journal of infection Control | - |
| 2019 - ongoing | Peer reviewer, Aust Hlth Rev | Peer Review | Australian Health Review | - |
Connect With Me
External Profiles
